Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

REGORAFENIB\REGORAFENIB vs REPAGLINIDE: Which Drug Is Safer?

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

REGORAFENIB\REGORAFENIB vs REPAGLINIDE: Safety Overview

Metric REGORAFENIB\REGORAFENIB REPAGLINIDE
Total FAERS Reports 106 2,544
Deaths Reported 32 169
Death Rate 30.2% 6.6%
Hospitalizations 39 1,517
Average Patient Age 60.5 yrs 71.9 yrs
% Female Patients 41.5% 45.5%
FDA Approval Date N/A Apr 24, 2015
Manufacturer N/A Rising Pharma Holdings, Inc.
Route N/A ORAL
Marketing Status N/A Discontinued